News

Akero Therapeutics, Inc. a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced that…
Read More...

VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, announced that Health Canada has approved PreHevbrio…
Read More...

Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, announces a development and supply agreement with Odimma Therapeutics, a French…
Read More...

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that Health Canada has approved a…
Read More...

Pfizer Inc. and Clear Creek Bio, Inc. announced a research collaboration and exclusive license agreement to advance the discovery and development of potential inhibitors of the…
Read More...

Kite Pharma, Inc., a Gilead Company, (hereafter Kite) and Daiichi Sankyo Co., Ltd. (hereafter, Daiichi Sankyo) jointly announced the revision of their 2017 partnership agreement, which…
Read More...

Aarvik Therapeutics announces a global license and assignment Agreement with NJ Bio, Inc. to secure a class of novel proprietary payloads with a wide range of potencies. Aarvik has…
Read More...

Caris Life Sciences(Caris), the leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare, and Hummingbird…
Read More...

Evaxion Biotech A/S announces that the Company has signed a Vaccine Discovery Collaboration Agreement with ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS…
Read More...

AbbVie and HotSpot Therapeutics, Inc., a biotechnology company pioneering the discovery and development of small molecule allosteric therapies for the treatment of cancer and autoimmune…
Read More...

Pfizer Inc. andBioNTech SE announced that the companies have submitted an application to the U.S. Food and Drug Administration (FDA) for emergency use authorization (EUA) of their…
Read More...

IDEAYA Biosciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to IDEAYA's development program investigating darovasertib, a…
Read More...

RedHill Biopharma Ltd. announced that the U.S. Food and Drug Administration's (FDA) Exclusivity Board has granted Aemcolo five years' exclusivity under the Generating Antibiotic…
Read More...

Solid Biosciences Inc., a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced the closing of its acquisition of…
Read More...

AbCellera and Rallybio Corporation announced that they have entered into a strategic alliance to discover, develop, and commercialize novel antibody-based therapeutics for rare…
Read More...

GSK plc announced that the European Medicines Agency (EMA) validated the marketing authorisation application (MAA) for momelotinib, a potential new oral treatment for myelofibrosis.…
Read More...

Immunocore Holdings plc, a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific immunotherapies designed to treat a…
Read More...

Rocket Pharmaceuticals, Inc. announces that it has completed the previously announced acquisition of Renovacor, Inc., a biotechnology company focused on delivering innovative precision…
Read More...

Solid Biosciences Inc. a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced the results of the special meeting of the…
Read More...

PTC Therapeutics, Inc. announced that the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved Waylivra (volanesorsen) as the first…
Read More...